Skip to content
Trial Eligibility
Menu

The ED-AWARENESS-2 Trial

NCT05534243

This study is recruiting at 4 US sites in 4 states, according to its ClinicalTrials.gov record last updated .

Summary

The investigators will screen all mechanically ventilated ED patients for study eligibility and will enroll all consecutive patients satisfying inclusion and exclusion criteria. The study design is a pragmatic, multicenter, stepped wedge cluster randomized trial, enrolling at five sites over a 3-year period, divided into six time periods of six months. Prior to the study, each site will be randomized to their position within the design. One site will cross to the intervention period (i.e. succinylcholine as default neuromuscular blocker) every six months from the 2nd to 6th time period.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Awareness
  • Mechanical Ventilation
  • Intubation Complication
  • PTSD

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Washington University School of Medicine
Last updated on ClinicalTrials.gov
October 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Iowa · 1

  • Roy J. and Lucille A. Carver College of Medicine · Iowa City, IA

Minnesota · 1

  • Hennepin Healthcare · Minneapolis, MN

New Jersey · 1

  • Cooper University Hospital/Cooper Medical School of Rowan University · Camden, NJ

Washington · 1

  • University of Washington School of Medicine · Seattle, WA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.